GENE ONLINE|News &
Opinion
Blog

2025-11-27|

Drones Transition from Deterrents to Non-Invasive Tools in Elephant Conservation Efforts

by GOAI
Share To

Recent findings highlight the evolving role of drones in elephant conservation efforts. Initially perceived as a source of disturbance, drones have transitioned into an effective and elephant-friendly tool for research and protection. Conservationists previously utilized drones to deter elephants from entering croplands by capitalizing on their tendency to flee from the devices. However, new observations suggest that elephants are capable of adapting to the presence of drones, paving the way for broader applications in wildlife monitoring.

Researchers have noted that elephants, known for their intelligence and adaptability, appear less alarmed by drones over time. This behavioral shift has opened opportunities for using drone technology in non-invasive ways to study elephant populations and habitats. The ability of drones to capture aerial footage provides researchers with valuable data on migration patterns, herd dynamics, and habitat usage without disrupting the animals’ natural behaviors. These advancements underscore the potential for drones to serve as a versatile tool in conservation strategies aimed at protecting elephant populations while minimizing human interference.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top